Archive | Innovation Challenge RSS feed for this section

Get Your Name Out – Win a Pitch Spot in the RESI Asia Innovation Challenge!

19 Sep

By Claire Jeong, Director of Research, Asia BD, LSN

claireAfter another successful RESI Boston last week, we are excited to talk about our inaugural RESI Asia events, RESI Shanghai (November 12th) and RESI Taipei (November 14th)!

Life Science Nation would like to invite all early-stage life science companies across the globe to apply for the RESI Asia Innovation Challenge through our online portal. Selected finalists will present a poster showcasing their company and technology at our exhibition hall on the day of RESI. All participants will be presented with “RESI Cash” to “invest” in their favorite technologies. This time, we have another special opportunity for the Innovation Challenge finalists!

For the very first time, our RESI Asia conferences will feature a full day track dedicated to pitch sessions, during which companies will present a short pitch in front of a panel of active investor judges. At both RESI Shanghai and RESI Taipei, companies who are selected for the Innovation Challenge will also be granted an opportunity to be part of a pitch session. In combination, the Innovation Challenge and pitch sessions will provide unparalleled exposure to participating early-stage companies who are seeking to meet and grow relationships with new and existing investors for their fundraising efforts.

To shed some light on what the Innovation Challenge is like from the participating company’s point of view, the 1st place winner of the Innovation Challenge at RESI Boston, Zepto Life Technology, shared some comments about their experience at RESI. Jason Payne, Director of Business Development & Investor Relations at Zepto, said, “The RESI Innovation Challenge provided a truly excellent opportunity for my team to showcase Zepto’s pioneering GMR-based “lab-on-a-chip” biotechnology, ahead of our firm’s upcoming $30 million Series A round in 1Q 2020. RESI’s team of well-practiced professionals equipped Zepto with expert guidance throughout each step of the process — from our team’s initial creation of Zepto’s poster through the entire RESI conference’s celebration of Zepto’s eventual 1st Place finish. Moreover, the RESI conference’s excellent web-based scheduling system allowed Zepto to launch our firm’s Series A outreach in style, introducing my team to numerous potential investors with a simple click of my mouse. Thanks to RESI, Zepto’s fundraising process is off to a wonderful start!”

Carmit Levy, CEO of ResMetrix Medical, 3rd place winner in the Innovation Challenge at RESI Boston, added, “The RESI Innovation Challenge provided a great opportunity for Resmetrix to present our unique wearable system for accurately monitoring lung disease patients at home and alert for early signs of deterioration. It opened the possibility to meet other participants that were interested to hear more about Resmetrix technology on top of the meetings that we set before with investors, through the wonderful meetup system on RESI website. Winning 3rd place in RESI challenge also exposed Resmetrix to additional potential investors. Thank you RESI for this great opportunity!”

I’ve also interviewed Soundable Health’s CEO Catherine Song, who won 1st place at the RESI Philadelphia Innovation Challenge in June (you can read it here).

Applying for the Innovation Challenge is free – get started on your application now!

RESI ASIA Innovation Challenge Deadline is Oct. 11th, 2019

From 38 Finalists, RESI Boston’s Audience Selects Innovation Challenge Champions

12 Sep

By Lucy Parkinson, VP of Investor Research, LSN

Yesterday’s RESI event brought together over 350 investors and over 350 startups in Boston’s Back Bay.  There were so many meetings that RESI Partnering filled to capacity.  LSN is delighted to have facilitated so many new connections, and we hope that these relationships continue to grow in the follow-up.

The RESI Innovation Challenge showcased 38 emerging startups in the biotech, medtech, diagnostics and digital health fields.  All the competitors brought novel, exciting discoveries to the technology showcase, selected by LSN’s Expert System and scientific review team.  RESI’s attendees chose the winners by using their RESI Cash tokens to cast votes for their favorite participants.  We would like to introduce you all to the 3 top placed companies, as selected by the RESI ecosystem.  Thank you, all, for taking part by casting your votes.

First Place: Zepto Life Technologies

Zepto, an in-vitro diagnostics company, features uniquely-accurate and multiplex-ready “lab-on-a-chip” technology – co-developed with the Mayo Clinic – to improve patient outcomes through superior assay performance at patients’ exact points of need (a $12B market). Zepto’s fully-automated lab-on-a-chip Immunoassay Platform can conveniently deliver “central lab-quality” performance almost anywhere. Initially, Zepto is working to equip ERs and ambulances with highly-sensitive Troponin assays, accelerating myocardial injury detection. Meanwhile, Zepto’s portable Liquid Biopsy Platform can detect 1% cancer gene mutation (eg. PIK3CA, EGFR, KRAS) and achieve unparalleled specificity of 99.9%+ in less than 2 hours. This can revolutionize the $6B tissue-based biopsy market. Zepto seeks $30M, primarily to launch the Immunoassay Platform with D-Dimer assays and complete PIK3CA-focused product development on the Liquid Biopsy Platform.

YongYong Zhang, CEO & Co-Founder, Zepto Life Technologies


Second Place: BOYDSense

BOYDSense, Inc. is a medical technology company providing non-invasive and affordable tools for measuring critical biomarkers via exhaled breath. Breath-based metabolomics focuses on the capture, identification, and quantification of volatile organic compound (VOC) biomarker patterns in human breath and using them to diagnose and monitor chronic diseases, such as diabetes. BOYDSense’s first commercial product, the g-Sense Breath Meter, is a hand-held breath meter that can accurately predict blood glucose values from breath VOC’s. The g-Sense meter does not need consumables, is wirelessly enabled, has a companion mobile application and a public API. The device design is lifestyle-friendly, pocket-sized, with a seamless user experience, allowing consumers to frequently measure blood glucose without the typical barriers of cost, pain, or social stigma.

Bruno Thuillier, CEO, BOYDSense


Third Place: Resmetrix Medical

Respiratory diseases are leading causes of death and disability in the world. More than 250 million people suffer from Chronic Obstructive Pulmonary disease (COPD) and 300 million from Asthma worldwide. Currently, respiratory deterioration is often detected too late, leading to sever exacerbation and complications, hospitalization and huge costs. Resmetrix is developing a wearable system (based on unique proprietary sensor built into a chest strap wirelessly connected to a smartphone app), that monitors at-risk respiratory patients in real-time, 24/7, anywhere, in any setting. Resmetrix system is the only system that detects small changes in a patient’s breathing pattern and provides immediate, early warning signs of deterioration in COPD patients at home, enable early window of intervention, early treatment and avoiding hospitalization.

Carmit Levy, Ph.D., CEO, Resmetrix Medical

RESI ASIA Innovation Challenge Deadline is Oct. 11th, 2019

Israeli Startups Make a Big Impact at RESI

12 Sep

By Karen Deyo, Senior Investor Research Analyst, LSN

Israel is frequently referred to as ‘The Startup Nation,’ with a lot of innovative technologies being developed in a multitude of sectors, including in healthcare. Over the past year, LSN has worked with the Israel Ministry of the Economy, the Israel Export Institute, the Israel Innovation Authority, the New England-Israel Business Council and several incubators and accelerators within Israel to bring these companies into the global RESI ecosystem.

In the 4 RESIs that have taken place so far in 2019, about 20 Israeli companies have been selected as finalists in the Innovation Challenge, with a few companies among the winners of these conferences. Yesterday, at RESI Boston, a group of these Israeli companies came to meet with the global investor attendees, including Novotalk, 1st place winner at RESI SF, PhotoPill Medical, 2nd place winner of RESI Europe, and Resmetrix, 3rd place winner yesterday. We look forward to seeing many more exciting companies from Israel at future RESIs, and hope that they will be as successful as the companies that have attended so far!

Izik Itzhakov of AEYE Health | Zohar Beeri of Novotalk | Ram Ben-Yehuda of PhotoPill Medical | Sharon Ben-Yehuda of PhotoPill Medical | Carmit Levy of Resmetrix Medical | Karen Deyo, Senior Investor Research Analyst, Life Science Nation

%d bloggers like this: